{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:36Z","timestamp":1753891836600,"version":"3.41.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802548, 81860451"],"award-info":[{"award-number":["81802548, 81860451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["202001AW070001, 202201AY070001-045, 202101AY070001-014, 2019FE001(-136), 2019FE001(-005)"],"award-info":[{"award-number":["202001AW070001, 202201AY070001-045, 202101AY070001-014, 2019FE001(-136), 2019FE001(-005)"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Presently, a comprehensive analysis of integrin subunit genes (ITGs) in bladder cancer (BLCA) is absent. This study endeavored to thoroughly analyze the utility of ITGs in BLCA through computer algorithm-based bioinformatics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>BLCA-related materials were sourced from reputable databases, The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). R software-based bioinformatics analyses included limma-differential expression analysis, survival-Cox analysis, glmnet-Least absolute shrinkage and selection operator (LASSO), clusterProfiler-functional annotation, and gsva-estimate-immune landscape analysis. The expression difference of key genes was verified by quantitative real-time polymerase chain reaction (qRT-PCR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 11 ITGs that were abnormally expressed in BLCA, ITGA7, ITGA5, and ITGB6 were categorized as the optimal variables for structuring the risk model. The high-risk subcategories were typified by brief survival, abysmal prognosis, prominent immune and stromal markers, and depressed tumor purity. The risk model was also an isolated indicator of the impact of clinical outcomes in BLCA patients. Moreover, the risk model, specifically the high-risk subcategory with inferior prognosis, became heavily interlinked with the immune-inflammatory response and smooth muscle contraction and relaxation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study determined three ITGs with prognostic values (ITGA7, ITGA5, and ITGB6), composed a novel (ITG-associated) prognostic gene signature, and preliminarily probed the latent molecular mechanisms of the model.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.970576","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T05:58:54Z","timestamp":1664863134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel prognostic model based on three integrin subunit genes-related signature for bladder cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Hongtao","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyou","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 global cancer statistics","volume-title":"Cancer Commun (Lond)","author":"Feng","year":"2019"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4111\/icu.2018.59.5.285","article-title":"Immune checkpoint inhibitors for urothelial carcinoma","volume":"59","author":"Kim","year":"2018","journal-title":"Invest Clin Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.1137","article-title":"Fibronectin, integrins, and growth control","volume":"189","author":"Danen","year":"2001","journal-title":"J Cell Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev.cellbio.19.031103.133334","article-title":"Positional control of cell fate through joint integrin\/receptor protein kinase signaling","volume":"19","author":"Giancotti","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-011-9341-9","article-title":"Integrin-epigenetics: a system with imperative impact on cancer","volume":"31","author":"Deb","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.01.007","article-title":"Integrin signaling in cancer: Mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance","volume":"35","author":"Cooper","year":"2019","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0077-T","article-title":"A molecular taxonomy for urothelial carcinoma","volume":"18","author":"Sj\u00f6dahl","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.03.084","article-title":"DNA Microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers","volume":"182","author":"Mengual","year":"2009","journal-title":"J Urol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.704067","article-title":"Comprehensive characterization of integrin subunit genes in human cancers","volume":"11","author":"Cui","year":"2021","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"Jvenn: An interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinf"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: Protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an r package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics J Integr Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1875-5364(19)30028-7","article-title":"Roles of integrin in tumor development and the target inhibitors","volume":"17","author":"Li","year":"2019","journal-title":"Chin J Natural Medicines."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S223201","article-title":"Integrin \u03b15\/ITGA5 promotes the proliferation, migration, invasion and progression of oral squamous carcinoma by epithelial-mesenchymal transition","volume":"11","author":"Deng","year":"2019","journal-title":"Cancer Manage Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4238\/2013.May.6.1","article-title":"Gene expression profile and enrichment pathways in different stages of bladder cancer","volume":"12","author":"Fang","year":"2013","journal-title":"Genet Mol Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.21037\/atm-21-1669","article-title":"Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK\/STAT3 signaling pathway","volume":"9","author":"Zheng","year":"2021","journal-title":"Ann Trans Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126303","article-title":"ITGB6-knockout suppresses cholangiocarcinoma cell migration and invasion with declining PODXL2 expression","volume":"22","author":"Soejima","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3892\/ijo.2019.4927","article-title":"Integrin \u03b17 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma","volume":"56","author":"Lv","year":"2020","journal-title":"Int J Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3892\/etm.2021.9740","article-title":"Integrin \u03b17 knockdown suppresses cell proliferation, migration, invasion and EMT in hepatocellular carcinoma","volume":"21","author":"Wu","year":"2021","journal-title":"Exp Ther Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.646252","article-title":"CXCL11 correlates with antitumor immunity and an improved prognosis in colon cancer","volume":"9","author":"Cao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.esmoop.2021.100118","article-title":"Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort","volume":"6","author":"Fornarini","year":"2021","journal-title":"ESMO Open"},{"key":"B31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12967-020-02698-x","article-title":"Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis","volume":"19","author":"Zhao","year":"2021","journal-title":"J Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA: Cancer J Clin"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19651","DOI":"10.1038\/s41598-020-76653-7","article-title":"Alterations in detrusor contractility in rat model of bladder cancer","volume":"10","author":"Philyppov","year":"2020","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.08.004","article-title":"Cancer-associated fibroblasts in desmoplastic tumors: Emerging role of integrins","volume":"62","author":"Zeltz","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09950-2","article-title":"Cohesive cancer invasion of the biophysical barrier of smooth muscle","volume":"40","author":"Harryman","year":"2021","journal-title":"Cancer metastasis Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: An update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2598","article-title":"Tumor purity as an underlying key factor in glioma","volume":"23","author":"Zhang","year":"2017","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.970576\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T05:58:58Z","timestamp":1664863138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.970576\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":39,"alternative-id":["10.3389\/fonc.2022.970576"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.970576","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"article-number":"970576"}}